The 2026 Precision Medicine World Conference (PMWC) Silicon Valley, co-hosted by Stanford, UCSF, and Yale, brought together leading experts from across the precision medicine ecosystem to advance the future of healthcare.
MADP Board Member, Dr. Burns Blaxall, was honored to serve as Chair of the Integration & Implementation of Precision Medicine track, facilitating important discussions focused on real-world clinical practice and expanding access to precision medicine at scale.
We invite you to explore the track chaired by Dr. Blaxall and review the important topics and expert discussions that are helping shape the future of patient care. [HERE]
Interested in attending the 2027 Precision Medicine World Conference? We welcome you to join global leaders in healthcare, research, genomics, biotechnology, and precision medicine for this premier annual event. Event registration and information [HERE].
MADP was honored to participate in the 2026 Virginia Public Health Summit on Cancer, held on June 2, 2026, at the Richmond Marriott Downtown in Richmond, Virginia.
Centered on the theme Data to Action, the summit brought together public health leaders, healthcare professionals, researchers, policymakers, and community organizations from across the Commonwealth to explore practical strategies for advancing cancer prevention, earlier detection, and improved health outcomes.
Discussions highlighted opportunities to strengthen cancer prevention initiatives, expand access to evidence-based screening and early detection, increase vaccination efforts, and support healthier communities throughout Virginia.
MADP was proud to join colleagues and partners committed to advancing public health and helping close the gap between scientific innovation and patient access.
We invite you to read reflections and highlights from the event in MADP CEO Cassandra Isley’s LinkedIn post [HERE], where she shares key takeaways from the summit.
We are especially proud of MADP Board Member Mia Masten, ELI-MP, CPC, for moderating this impactful statewide signature conference bringing together voices across biotechnology, research, and public health.
MADP appreciates John Newby, CEO of Virginia Bio, and Caron Trumbo, VP of Operations, for their continued leadership in driving innovation, collaboration, and growth across the biotechnology sector. Their work continues to unite innovators and researchers committed to improving lives through science.
Together, we are advancing a future where scientific discovery translates into better health outcomes for all communities. We invite you to explore more moments from this impactful event on the MADP LinkedIn page [HERE].
Cassandra Isley, CEO of MADP, Speaks at Impact 100 RVA “The Big Event”
Cassandra Isley, Chief Executive Officer of MADP Alliance for Disease Prevention, had the honor of serving as a guest speaker in March at Impact 100 RVA The Big Event in Richmond.
During her remarks, she addressed the critical importance of women’s health and the role of prevention in reducing the burden of chronic disease. She emphasized how proactive conversations with healthcare providers – particularly during annual well visits – can help identify risk earlier through appropriate, guideline-informed blood testing.
By advancing awareness of earlier detection and smarter screening, MADP continues to empower individuals with the knowledge needed to help prevent cancer and cardiovascular disease – delivering on its mission of expanding access to precision medicine for all communities.
